Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin + Metformin for Weight Maintenance in PCOS
NCT02941445Phase 4Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Oct 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of sitagliptin in obesity and polycystic ovary syndrome (PCOS) (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Change in body weight at 12 weeks. Started Oct 2015; status: completed.
02
Drugs
sitagliptin
03
Conditions
obesitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT02941445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02941445.